Arrhythmias & electrophysiology

Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study

CirculationPublished Prospective cohort study

Authors' conclusion

The entire population of asymptomatic patients with BrECG exhibits a relatively low event rate per year, which is important in view of the long life expectancy of these young patients. The presence of spontaneous type-1 BrECG associated with positive EPS identifies a subgroup at higher risk.

Study context

Population
Asymptomatic patients with Brugada ECG pattern (BrECG), 2 Italian centresfollow-up 2 to 22 years
Participants
1,149 patients
Exposure
Spontaneous type-1 BrECG vs drug-induced-only type-1 BrECG
  • Spontaneous type 1n = 539
  • Drug-induced type 1n = 610reference
Outcome
Arrhythmic events (sudden death or documented VF or VT)
Follow-up
Median 6 (4-9) years
Methodological details2 Italian centres, consecutive patients
  • 2 Italian centres
  • Consecutive patients

Main finding

As reported in the abstract

Arrhythmic events · median 6 years

Spontaneous type 1

0.4% per year

16 of 539

Drug-induced type 1

0.03% per year

1 of 610

P < 0.001

Overall asymptomatic population: 17 (1.5%) events
0.2% per year

Observational data: associations, not effects.

Further findings

Per year

OutcomePositive EPSNegative EPSDeclined EPSP value
Arrhythmic events by EPS result (spontaneous type 1)Positive EPS vs Negative EPS · 7 of 103 vs 4 of 2360.7%0.2%0.4%P = 0.025
  • Arrhythmic events by electrophysiologic study (EPS) result (spontaneous type 1): EPS performed in 339 (63%) with spontaneous type 1; 200 declined EPS

Device-related death

Device-related death
1

Original publication

Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study. Circulation. Published 13 October 2023. doi:10.1161/circulationaha.123.064689

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.